Valsartan is a widely-used prescription drug used to treat high blood pressure. It is also known by its generic name, Diovan. As with any medication, it is important to understand and follow the proper dosage instructions in order to ensure that your health remains safe. But how much Valsartan is too much? In this blog post, we’ll discuss what the right dose of Valsartan is and why it’s important to pay attention to the amount you take. We’ll also cover potential side effects of taking too much and how you can avoid them. Read on for more!
Valsartan is an angiotensin II receptor antagonist (ATRA) used to treat high blood pressure, congestive heart failure, and to reduce the risk of strokes. It works by relaxing blood vessels so that blood can flow more easily. It is also used in some patients after a heart attack. Valsartan can be taken with or without food.
Common side effects of Valsartan may include dizziness, headache, nausea, and diarrhea.
The recommended doses of Valsartan vary depending on the condition being treated. For hypertension, the usual recommended starting dose is 80 mg once daily. The dosage may be increased to a maximum of 320 mg once daily if needed. For congestive heart failure, the starting dose is 40 mg twice daily, with the dosage gradually increased as needed up to a maximum of 160 mg twice daily.
1. Dizziness
2. Lightheadedness
3. Fatigue
4. Nausea
5. Diarrhea
6. Headache
7. Dry mouth
8. Increased urination
If you are prescribed Valsartan, it is important to take the correct dose. The amount of medicine that you need to take may be different for different people.
If you miss a dose of Valsartan, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses of Valsartan at the same time.
Taking too much valsartan dosage can be dangerous, so it is important to understand the correct dosage for your condition.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation